Use of the inhibitory effect of apoptotic cells on dendritic cells for graft survival via T-cell deletion and regulatory T cells

American Journal of Transplantation

Volumn 6, Issue 6, 2006, Pages 1297-1311

  Wang, Z ^a   Larregina, A T ^a   Shufesky, W J ^a   Perone, M J ^a   Montecalvo, A ^a   Zahorchak, A F ^a   Thomson, A W ^a   Morelli, A E ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Donor specific transfusion; Immunosuppression; Indirect pathway; Lymphocyte activation; Transplantation

Indexed keywords

ALLOANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CD8ALPHA ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 15 RECEPTOR; INTERLEUKIN 2; INTERLEUKIN 7 RECEPTOR; PROTEIN BCL XL;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; B LYMPHOCYTE ACTIVATION; CARDIAC GRAFT REJECTION; CELL ACTIVITY; CELL FUNCTION; CELL INTERACTION; CELL MATURATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; GRAFT SURVIVAL; HEART TRANSPLANTATION; HISTOCOMPATIBILITY; HOMEOSTASIS; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T CELL DEPLETION; T LYMPHOCYTE ACTIVATION;

ANIMALS; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; GRAFT SURVIVAL; HEART TRANSPLANTATION; ISOANTIBODIES; LYMPH NODES; LYMPHOCYTE CULTURE TEST, MIXED; LYMPHOCYTE DEPLETION; LYMPHOCYTE TRANSFUSION; MICE; MICE, INBRED BALB C; MICE, INBRED STRAINS; MODELS, ANIMAL; SPLEEN; TRANSPLANTATION, HOMOLOGOUS; ULTRAVIOLET RAYS;

EID: 33745822826     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2006.01308.x     Document Type: Article

References (47)

1. Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, Girkontaite I. Immunosuppressive effects of apoptotic cells. Nature 1997; 390: 350-351.
2. Verbovetski I, Bychkov H, Trahtemberg U et al. Opsonization of apoptotic cells by autologous iC3b facilitates clearance by immature dendritic cells, down-regulates DR and CD86, and upregulates CC chemokine receptor 7. J Exp Med 2000; 196: 1553-1561.
3. Stuart LM, Lucas M, Simpson C, Lamb J, Savill J, Lacy-Hulbert A. Inhibitory effects of apoptotic cell ingestion upon endotoxin-driven myeloid dendritic cell maturation. J Immunol 2002; 168: 1627-1635.
4. Morelli AE, Larregina AT, Shufesky WJ et al. Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: Dependence on complement receptors and effect on cytokine production. Blood 2003; 101: 611-620.
5. Steinman RM, Nussenzweig MC. Avoiding horror autotoxicous: The importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci USA 2002; 99: 351-358.
6. Steinman RM, Turley S, Mellman I, Inaba K. The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med 2000; 191: 411-416.
7. -) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation 1996; 62: 659-665.
8. Lutz MB, Suri RM, Niimi M et al. Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur J Immunol 2000; 30: 1813-1822.
9. Gregori S, Casorati M, Amuchastegui S, Smiroldo S, Davalli AM, Adorini L. Regulatory T cells induced by 1-alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol 2001; 167: 1945-1953.
10. Mirenda V, Berton I, Read J et al. Modified dendritic cells co-expressing self and allogeneic major histocompatibility complex molecules: An efficient way to induce indirect pathway regulation. J Am Soc Nephrol 2004; 15: 987-997.
11. Morelli AE, Thomson AW. Dendritic cells: Regulators of alloimmunity and opportunities for tolerance induction. Immunol Rev 2003; 196: 125-146.
12. Lechler R, Ng WF, Steinman RM. Dendritic cells in transplantation - Friend or foe? Immunity 2001; 14: 357-368.
13. Wilson NS, El-Sukkari D, Belz GT et al. Most lymphoid organ dendritic cell types are phenotypically and functionally immature. Blood 2003; 102: 2187-2194.
14. + T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells. J Exp Med 1998; 187: 1555-1564.
15. Kurts C, Kosaka H, Carbone FR, Miller JF, Heath WR. Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. J Exp Med 1997; 186: 239-245.
16. Horan PK, Slezak SE. Stable cell membrane labeling. Nature 1989; 340: 167-168.
17. Arkenasy N, Farkas DL. Optical Imaging of PKH-labeled hematopoietic cells in recipient bone marrow in vivo. Stem Cells 2002; 20: 501-513.
18. Rudensky AY, Preston-Hurlburt P, Hong S-C, Barlow A, Janeway Jr CA. Sequence analysis of peptide bound to MHC class II molecules. Nature 1991; 353: 622-627.
19. Wells AD, Gudmundsdottir H, Turka LA. Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response. J Clin Invest 1997; 100: 3173-3183.
20. Viret C, Janeway CA Jr. Functional and phenotypic evidence for presentation of E alpha 52-68 structurally related self-peptide(s) in I-E alpha-deficient mice. J Immunol 2000; 164: 4627-4634.
21. Gett AV, Sallusto F, Lanzavecchia A, Geginat J. T cell fitness determined by signal strength. Nat Immunol 2003; 4: 355-360.
22. Li XC, Demirci G, Ferrari-Lacraz S, Groves C, Coyle A, Malek TR et al. IL-15 and IL-2: a matter of life and death for T cells in vivo. Nature Med 2001; 7: 114-118.
23. Schluns KS, Kieper WC, Jameson SC, Lefrancois L. Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo. Nat Immunol 2000; 1: 426-432.
24. Vander Heiden MG, Thompson CB. Bcl-2 proteins: Regulators of apoptosis or of mitochondrial homeostasis? Nat Cell Biol 1999; 1: E209-E216.
25. Mevorach D, Zhou JL, Song X, Elkon KB. Systemic exposure to irradiated apoptotic cells induces autoantibody production. J Exp Med 1998; 188: 387-392.
26. Rovere P, Vallinoto C, Bondanza A et al. Bystander apoptotic cells trigger dendritic cell maturation and antigen-presenting function. J Immunol 1998; 161: 4467-4471.
27. Liu K, Iyoda T, Saternus M, Kimura Y, Inaba K, Steinman RM. Immune tolerance after delivery of dying cells to dendritic cells in situ. J Exp Med 2002; 196: 1091-1097.
28. + dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J Exp Med 2002; 195: 1289-1302.
29. Albert ML, Sauter B, Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998; 392: 86-89.
30. Hawiger D, Inaba K, Dorsett Y et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med 2001; 194: 769-779.
31. + T cell tolerance. J Exp Med 2002; 196: 1627-1638.
32. Xu DL, Liu Y, Tan MJM et al. Marked prolongation of murine cardiac allograft survival using recipient immature dendritic cells loaded with donor-derived apoptotic cells. Scan J Immunol 2004; 59: 536-544.
33. Feng H, Zeng Y, Whitesell L, Katsanis E. Stressed apoptotic tumor cells express heat shock proteins and elicited tumor-specific immunity. Blood 2001; 97: 3505-3512.
34. Yrlid U, Wick MJ. Salmonella-induced apoptosis of infected macrophages results in presentation of a bacteria-encoded antigen after uptake by bystander dendritic cells. J Exp Med 2000; 191: 613-623.
35. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 1998; 101: 890-898.
36. + dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. J Exp Med 2002; 196: 1099-1104.
37. Ferguson TA, Herndon J, Elzey B, Griffith TS, Schoenberger S, Green DR. Uptake of apoptotic antigen-coupled cells by lymphoid dendritic cells and cross-priming of CD8α+ T cells produce active immune unresponsiveness. J Immunol 2002; 168: 5589-5595.
38. Iezzi G, Karjalainen K, Lanzavecchia A. The duration of antigenic stimulation determines the fate of naïve and effector T cells. Immunity 1998; 8: 89-95.
39. Larsen CP, Elwood ET, Alexander DZ et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996; 381: 434-438.
40. Li Y, Li XC, Zheng XX, Wells AD, Turka LA, Strom TB. Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance. Nature Med 1999; 5: 1298-1302.
41. Quezada SA, Fuller B, Jarvinen LZ et al. Mechanisms of donor-specific transfusion tolerance: Preemptive induction of clonal T-cell exhaustion via indirect presentation. Blood 2003; 102: 1920-1926.
42. L. Immunity 1995; 3: 87-98.
43. Barroso Herrera O, Golshayan D, Tibbott R et al. A novel pathway of alloantigen presentation by dendritic cells. J Immunol 2004; 173: 4828-4837.
44. Wells AD, Li XC, Li Y et al. Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. Nat Med 1999; 11: 1303-1307.
45. Walsh PT, Taylor DK, Turka LA. Tregs and transplant tolerance. J Clin Invest 2004; 114: 1398-1403.
46. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003; 3: 199-206.
47. Maeda A, Schwarz A, Kernebeck K et al. Intravenous infusion of syngeneic apoptotic cells by photopheresis induces antigen-specific regulatory T cells. J Immunol 2005; 174: 5968-5976.